EpimiRNA
Bicoll © Kai Lamottke
Bicoll © Kai Lamottke

Partner 13 Interna Technologies BV

 

Dr. Roel Schaapveld Interna Technologies BV

Dr. Roel Schaapveld

Principal Investigator

Phone: +31 302532386

Fax: +31 302539176

undefinedE-Mail

Interna Technologies BV

Jonkerbosplein 52

6534 AB Nijmegen

The Netherlands

undefinedWebsite

 

 

 

 

 

EpimiRNA InteRNA Members

 

Dr. Paula van Noort           

Director R&D

Phone: +31 302539549

Fax: +31 302539176

undefinedE-Mail

 

 

Thijs De Gunst, M.Sc.

 

Technician

 

undefinedE-Mail

Institue presentation

InteRNA is a Dutch drug discovery and development company engaged in the development of novel breakthrough therapies in chronic disorders, e.g. cancer and CNS diseases, based on the unique functions of its proprietary miRNAs. InteRNA's drug development programs aim at developing miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes that are known to play a role in the initiation and progression of chronic disorders. At present, miRNA findings are captured in seven patent families all claiming miRNAs key in the diagnosis or treatment of chronic disorders.

This EpiMiRNA project benefits from InteRNA’s platform for discovery and validation of miRNA-based drug candidates which is based on its proprietary lentiviral-based miRNA expression library (which is the largest currently available) that allows for high throughput functional screening in cell based assays. With InteRNA's proprietary miRNA expression database (generated through deep sequencing) and additional technologies (like RNAseq, PAR-CLIP, bioinformatics, in vivo models) in place to identify the downstream regulated proteins for each miRNA drug candidate, InteRNA has the platforms in place to move novel miRNA drug candidates with their biomarkers quickly towards the clinic.

InteRNA has four years of experience in project management as consortium leader in a Dutch-based consortium with academic partners funded by Top Institute Pharma, was and is still partner in several national or international public sponsored research projects, e.g. the Sirocco FP6 and MiRacle FP7 projects, and has multiple international academic and corporate R&D partners.

EpimiRNA Team

EpimiRNA Work packages

EpimiRNA Work packages
Home
Top

Newsletter Subscription

EpimiRNA on @twitter

News Section

EpimiRNA Coordinator Prof. David Henshall gave a RCSI MyHealth Lecture on...

Read more

Social Media

Twitter Google Plus Facebook
Home
Top